Oncolytics Biotech, Inc. (ONCY)
1.04
+0.10
(+11.23%)
USD |
NASDAQ |
May 29, 16:00
1.07
+0.03
(+2.88%)
After-Hours: 20:00
Oncolytics Biotech Shareholders Equity (Quarterly) : -5.13M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Replimune Group, Inc. | 210.54M |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.505B |
| Anixa Biosciences, Inc. | 15.08M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.161M |
| Total Liabilities (Quarterly) | 13.29M |
| Debt to Equity Ratio | -0.099 |
| Current Ratio | 1.381 |
| Net Debt Paydown Yield | 0.05% |